[Retracted] Value of a Signature of Immune-Related Genes in Predicting the Prognosis of Melanoma and Its Responses to Immune Checkpoint Blocker Therapies

Table 1

Results of univariate Cox analyses.

Gene	Cohort 2: 69 samples of primary melanoma				All TCGA-SKM samples				GSE53118: 79 metastasized melanoma samples
	HR	Low 95% CI	High 95% CI	Log rank	HR	Low 95% CI	High 95% CI	Log rank	HR	Low 95% CI	High 95% CI	Log rank
CD14	1.00540	1.00039	1.01043	0.02970	0.58732	0.44774	0.77042	0.00012	0.73561	0.56706	0.95424	0.01956
CMKLR1	1.15676	1.01574	1.31737	0.02402	0.62832	0.47988	0.82269	0.00073	0.38604	0.17158	0.86857	0.01976
HCK	1.06897	1.01007	1.13130	0.01867	0.53355	0.40626	0.70074	0.00001	0.64748	0.44118	0.95023	0.02515
ITGB2	1.02357	1.00469	1.04280	0.01090	0.55908	0.42627	0.73328	0.00003	0.77982	0.61092	0.99541	0.04441
PTAFR	1.11806	1.03635	1.20622	0.00231	0.60681	0.46314	0.79504	0.00029	0.33987	0.14557	0.79352	0.01181